// App-Quantinova.ai

1001 : Challenges in Treatment of Patients with Acute Leukemia and COVID-19 – a Series of 12 Patients

Researchers

Presenter

  • Susanne Ghandili

Principal Investigators

  • Susanne Pfefferle

  • Kevin Roedl

  • Piet Sonnemann

  • Panagiotis Karagiannis

  • Olaf Boenisch

  • Stefan Kluge

  • Stefan Schmiedel

  • Harald Ittrich

  • Holger Rohde

  • Marc Ltgehetmann

  • Katja Weisel

  • Carsten Bokemeyer

  • Dominic Wichmann

  • Walter Fiedler

  • Dominik Jarczak

  • Franziska Modemann

Medical Centers

  • Department of Oncology, Haematology and Bone Marrow Transplantation with section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  • Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • Department for Transfusion Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  • Department of Medicine, Section Infectious Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  • Department of Diagnostic and Interventional Radiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  • Department of Oncology, Haematology and Bone Marrow Transplantation with section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  • Department of Oncology, Haematology and Bone Marrow Transplantation with section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  • Department of Oncology, Haematology and Bone Marrow Transplantation with section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Acute lung injury

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

  • Coronavirus disease

  • Severe COVID-19 pneumonia

  • Acute Leukemia

  • Lymphomas

Biomarkers

  • Breakpoint Cluster Region

  • Immunoglobulin G

Drug/Treatment

  • Vidaza

  • Venetoclax

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A